The Seer spinoff recently closed a $46 million funding round that it is using to support efforts in nucleic acid, proteomic, and metabolomic biomarker discovery.
Read the full article in GenomeWeb here.
March 1, 2024
Multi-Omics Could be Key in Expanding Liquid Biopsy
July 13, 2023
Apparently Getting Smarter Makes Us Healthier: AI And Data Analysis Revolutionize Healthcare
June 21, 2022
PrognomiQ partners with KSM to discover cancer biomarkers
